Clinical Trial Update: BIO 300 Non-Small Cell Lung Cancer Study [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 trial update for BIO 300 in non-small cell lung cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BIO 300

Snippet

Sponsor: Humanetics Corporation | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-20